Semaglutide injection pen used to improve blood sugar control in adults with type 2 diabetes. 0.5 mg dose.
Contains semaglutide, a GLP-1 receptor agonist. Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes, and to reduce the risk of major cardiovascular events and kidney disease progression in adults with type 2 diabetes and established cardiovascular or kidney disease.
Attributes
Product Content
How to Use:
• Inject subcutaneously once weekly in the abdomen, thigh, or upper arm, any time of day, with or without food.
• This 0.5 mg strength is typically the first maintenance dose, reached after a 0.25 mg titration month.
• May be increased to 1 mg and then 2 mg weekly if needed, at least 4 weeks apart.
The link to Ozempic 0.5mg Subcutaneous 1 Prefilled Pen (Refrigerated) has been copied